(Q39834084)

15 September 2017

In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum (English)

1 reference

15 September 2017

0 references

0 references

Conrad DA

1

1 reference

15 September 2017

Scribner RK

series ordinal

2

1 reference

15 September 2017

Weber AH

series ordinal

3

1 reference

15 September 2017

Marks MI

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 July 1985

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

1

1 reference

15 September 2017

58-63

1 reference

Comparative activities of 13 beta-lactam antibiotics

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Antagonists of Nucleic Acid Derivatives Viii. Synergism in Combinations of Biochemically Related Antimetabolites

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Ceftazidime in septicaemia

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Clinical experience with ceftazidime in urology in Japan

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including ‘tolerant’ micro-organisms

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176310

A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia

20 August 2018

1 reference

12 December 2020

Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response

1 reference

12 December 2020

Experience with ceftazidime in cystic fibrosis

1 reference

12 December 2020

Discrepancies between in vitro activity of and in vivo response to antimicrobial agents

1 reference

12 December 2020

Pharmaceutics of penicillin

1 reference

12 December 2020

MECHANISM OF DEGRADATION OF PENICILLIN G IN ACIDIC SOLUTION

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.28.1.58

1 reference

15 September 2017

1 reference

15 September 2017

1 reference